Modeling and real-time prediction of classical swine fever epidemics

We propose a new method to analyze outbreak data of an infectious disease such as classical swine fever. The underlying model is a two-type branching process. It is used to deduce information concerning the epidemic from detected cases. In particular, the method leads to prediction of the future course of the epidemic and hence can be used as a basis for control policy decisions. We test the model with data from the large 1997-1998 classical swine fever epidemic in The Netherlands. It turns out that our results are in good agreement with the data.     

Synthesis and antiviral activity of a novel glycosyl sulfoxide against classical swine fever virus

A novel compound—2″,3″,4″,6″-tetra-O-acetyl-β-d-galactopyranosyl-(1→4)-2′,3′,6′-tri-O-acetyl-1-thio-β-d-glucopyranosyl-(5-nitro-2-pyridyl) sulfoxide—designated GP6 was synthesized and assayed for cytotoxicity and in vitro antiviral properties against classical swine fever virus (CSFV) in this study. We showed that the examined compound effectively arrested CSFV growth in swine kidney cells (SK6) at a 50% inhibitory concentration (IC₅₀) of 5 ± 0.12 μg/ml without significant toxicity for mammalian cells. Moreover, GP6 reduced the viral E2 and E^rns glycoproteins expression in a dose-dependent manner. We have excluded the possibility that the inhibitor acts at the replication step of virus life cycle as assessed by monitoring of RNA level in cells and culture medium of SK6 cells after single round of infection as a function of GP6 treatment. Using recombinant E^rns and E2 proteins of classical swine fever virus produced in baculovirus expression system we have demonstrated that GP6 did not influence glycoprotein production and maturation in insect cells. In contrast to mammalian glycosylation pathway, insect cells support only the ER-dependent early steps of this process. Therefore, we concluded that the late steps of glycosylation process are probably the main targets of GP6. Due to the observed antiviral effect accompanied by low cytotoxicity, this inhibitor represents potential candidate for the development of antiviral agents for anti-flavivirus therapy. Further experiments are needed for investigating whether this compound can be used as a safe antiviral agent against other viruses from unrelated groups.     

猪瘟病毒Core蛋白核仁定位序列鉴定

黄病毒科病毒核衣壳蛋白的核仁定位在病毒颗粒包装与病毒复制中发挥重要作用。为鉴定黄病毒科的猪瘟病毒Core蛋白核仁定位序列,本研究构建了将Core蛋白、截短突变体和氨基酸位点突变体分别与增强型绿色荧光蛋白(enhanced green fluorescent protein, EGFP )融合的真核表达质粒,转染至PK15细胞后进行表达和定位分析,结果显示 Core蛋白核仁定位序列为PESRKKL,其关键氨基酸为R76K77,对理解猪瘟病毒Core蛋白结构与功能和为后续研究Core蛋白在病毒复制及颗粒包装中的作用有重要意义。     

Development of multiple elisas for the detection of antibodies against classical swine fever virus in pig sera

The major immunogenic proteins (Ems,E2 and NS3) of classical swine fever virus (CSFV) (Shimen strain) were expressed in E.coli and purified by affinity chromatography.The recombinant antigens were appl...     

猪瘟病毒与宿主天然免疫系统的相互作用

猪瘟(Classical swine fever,CSF)是由猪瘟病毒(Classical swine fever virus,CSFV)感染引起的一种高度接触性传染病,临床上以出血综合征与免疫抑制为主要特征。它在多个国家流行,给中国乃至世界养猪业造成巨大的经济损失。研究表明,猪瘟病毒感染能够诱导宿主的天然免疫应答,也能通过影响天然免疫效应分子的表达来抑制宿主的天然免疫功能。本文将对猪瘟病毒感染与天然免疫应答及其免疫抑制的现象与机理进行综述。     

Proteomic analysis of primary porcine endothelial cells after infection by classical swine fever virus

Endothelial cells are the main target of classical swine fever virus during infection, and extensive hemorrhage is the most typical clinical sign of classical swine fever. To investigate the molecular mechanism of hemorrhagic pathogenesis, two-dimensional difference gel electrophoresis with fluorescent dyes (2D-DIGE) was used to analyze the proteomic profile of primary porcine umbilical vein endothelial cells (PUVECs) following CSFV infection. Of 15 protein spots with differential expression, 8 were characterized by MALDI-TOF-MS/MS in infected PUVECs at 48 h p.i.: moesin, peroxiredoxin 6, stathmin-1, a protein similar to nascent polypeptide-associated complex alpha subunit isoform 2, phosphoglycerate kinase 1, glucosidase II, transketolase and α-tubulin. These could be sorted into 5 functional groups: glycometabolism, cell proliferation, anti-oxidative stress, inflammatory response and cytoskeleton. Western blot and real-time RT-PCR analysis confirmed the down-regulation of phosphoglycerate kinase 1 (PGK1) and up-regulation of moesin identified by 2D-DIGE. Pathway analysis of these 15 differentially expressed proteins showed that CSFV infection altered the metabolism, cytoskeleton and cell proliferation of PUVECs, and that consequently an inflammatory response was induced.     

新型猪瘟疫苗研究进展

猪瘟是由猪瘟病毒引起猪的一种急性、热性和高度接触性传染病.该病呈世界性分布,给世界养猪业造成了巨大的经济损失.目前,疫苗接种仍然是防控猪瘟的主要手段.虽然传统的猪瘟弱毒疫苗(如C株)安全有效,但猪瘟的临床表现发生了很大变化,呈现典型猪瘟和非典型猪瘟共存、隐性感染和持续感染并现,免疫失败的现象时有报道,且不能区分野毒感染和免疫接种.因此,研制安全、高效、能区分野毒感染和疫苗免疫动物(DIVA)的新型猪瘟疫苗极为必要.文中就近年来开发的核酸疫苗、病毒活载体疫苗、基于蛋白/肽的疫苗、基因缺失疫苗、嵌合瘟病毒疫苗等新型DIVA猪瘟疫苗作一综述.     

非洲猪瘟病毒的免疫逃逸策略

非洲猪瘟(African swine fever,ASF)是由非洲猪瘟病毒(African swine fever virus,ASFV)引起的一种猪烈性传染病。目前无商品化的ASF疫苗,一旦发病,仅能依靠快速扑杀进行防控,严重威胁我国养猪及相关行业的健康发展。ASF疫苗研发面临的主要困难是对ASFV的毒力相关基因、致病及其免疫逃逸机制知之甚少。本文对ASFV的免疫逃逸研究进行了总结,探讨了ASFV免疫逃逸基因及其编码蛋白的功能,以便加深对ASFV及其免疫逃逸策略的认知,为致病机制研究和疫苗研发提供借鉴。     

基于Semliki Forest病毒RNA复制子的猪瘟RNA疫苗初步研究

将猪瘟病毒E2基因克隆于我们此前构建的衍生于Semliki Forest病毒(semliki forest virus,SFV)RNA复制子的新型真核表达载体pSFV1CS中,获得重组质粒pSFV1CS-E2。用纯化的pSFV1CS-E2分别转染BHK-21细胞和293T细胞,经间接免疫荧光试验检测显示,CSFV E2基因在转染细胞中得到表达。小鼠接种试验结果表明,10μg或100μg pSFV1CS-E2可诱导小鼠产生猪瘟特异性抗体。     

六种检测猪瘟病毒方法的比较

【目的】本研究旨在比较6种检测猪瘟病毒方法的优缺点。【方法】应用病毒分离、胶体金免疫层析试纸条、抗原捕捉ELISA、反转录-聚合酶链式反应(RT-PCR)、TaqMan荧光定量RT-PCR(RT-qPCR)和反转录-环介导等温扩增方法(RT-LAMP)等6种方法,分别对50份疑似猪瘟病料中的猪瘟病毒(Classical swine fevervirus,CSFV)进行检测。【结果】结果表明:RT-qPCR和RT-LAMP方法检出阳性样品数为13份,RT-PCR为11份,病毒分离为10份,抗原捕捉ELISA为9份,胶体金试纸条为8份;6种方法均检测为阳性8份,均为阴性37份。【结论】结果提示,在对猪瘟病毒进行检测时,RT-qPCR、RT-LAMP和RT-PCR由于其灵敏性高,可作为首选检测方法,但操作时需要避免假阳性的出现;病毒分离方法虽然操作繁琐,但结果准确,是确诊猪瘟必不可少的检测方法;抗原捕捉ELISA和胶体金试纸条检测时间较短,由于其敏感性较低所限,主要用于对畜群进行检测,不适合个体检测。     

通过基因组定量研究猪瘟病毒在细胞中的增殖特性

应用间接免疫荧光、Real-time PCR和病毒感染滴度(TCID50)测定技术,分别从病毒抗原、病毒基因组RNA复制水平和病毒感染滴度变化3个方面,研究了猪瘟病毒(CSFV)在PK-15细胞中增殖的特点,用猪瘟病毒石门株感染96孔板培养的细胞,1×102个TCID50/孔,间接免疫荧光检测结果显示感染后8h能检测到被荧光抗体染色的感染细胞,随感染时间的延长,出现荧光的细胞数量逐渐增多,在感染后72h,几乎所有细胞均能出现荧光。Real-time PCR结果显示在细胞感染初期的8~24h,病毒的基因组RNA复制呈加速趋势,其拷贝数在感染后72h达到高峰。此外,在感染后8h能检测到病毒基因组负链RNA转录,不过负链RNA在病毒增殖过程中维持在较低的水平。TCID50测定结果表明CSFV的感染滴度增加趋势与基因组类似,在病毒感染8h后能检测到具有感染性的子代病毒,感染滴度在8~20h之间逐渐增长,24~48h之间增长速度稍减慢,在感染后48~52h达到高峰,能在72h之内维持较高的感染滴度。     

反向遗传学技术在猪瘟病毒研究中的应用

猪瘟目前在许多国家流行并对养猪业造成巨大损失。虽然常规疫苗(如中国猪瘟兔化弱毒疫苗,即C株)在猪瘟防控中发挥巨大作用,但近年来在猪瘟防控中出现的新情况,如非典型感染、持续性感染及免疫失败等;同时目前世界上许多国家正开展的猪瘟扑灭计划使得弱毒疫苗的应用受到很大限制。因此,加强猪瘟病毒在致病机理、传播机制等方面的研究以及加快新型猪瘟疫苗的开发是当务之急。近年来,反向遗传学技术的发展为猪瘟病毒基因功能研究和疫苗制备方面开辟了新思路。以下回顾了反向遗传操作技术在猪瘟病毒基因功能研究与标记疫苗株构建方面的研究进展,同时提出了该领域目前面临的问题,并对其未来发展方向进行了展望。     

猪瘟DNA疫苗研究进展

自1990年DNA疫苗问世以来,已有许多研究者构建了不同类型的DNA疫苗。这些载体能诱发机体产生不同程度的特异性体液免疫和(或)细胞免疫。研究者们也在猪瘟DNA疫苗研究方面做出了很多努力并取得了一定的成果。以下从猪瘟DNA疫苗的构建和评价、佐剂在猪瘟DNA疫苗中的应用、猪瘟DNA疫苗与其他疫苗的联合应用以及目前猪瘟DNA疫苗存在的问题和解决途径等方面做了比较全面的阐述。     

非洲猪瘟防控及疫苗研发：挑战与对策

非洲猪瘟是由非洲猪瘟病毒引起的一种接触传染性、广泛出血性猪烈性传染病,最急性和急性感染死亡率高达100%。自2018年8月我国发生首起非洲猪瘟疫情后,3个多月内,已有18个省份累计暴发69起,给我国养猪业造成了沉重打击。从目前非洲猪瘟全球流行态势及世界各国防控经验来看,我国非洲猪瘟防控和根除面临的形势不容乐观,亟需安全有效的疫苗用于该病的防控。文中结合当前非洲猪瘟病原学最新研究成果,系统总结了非洲猪瘟防控策略、疫苗研究进展及其面临的挑战,重点分析了疫苗研发历程、存在的问题、未来发展方向以及商业化应用所面临的关键科学问题,以期为我国非洲猪瘟防控及病原和疫苗研究提供借鉴。     

Expression and functional characterization of classical swine fever virus E(rns) protein

E(rns) is an envelope glycoprotein of classical swine fever virus (CSFV) with unusual RNase activity. Recently, E(rns) was found to have a new function of counteracting the beta-interferon (IFN-beta) induction pathway. In this study, wildtype ErnsSM and two mutated E(rns) proteins ErnsH297k and ErnsH346k were expressed in insect cells and purified for RNase activity and function analysis. RNase activity assay in vitro demonstrated that only wildtype E(rns) protein had RNase activity. However, both wildtype ErnsSM and the two mutated E(rns)ErnsH297k and ErnsH346k as exogenous proteins had a block effect on Newcastle disease virus (NDV)-mediated IFN-beta promoter induction.     

Oral immunisation of wild boar against classical swine fever: uptake studies of new baits and investigations on the stability of lyophilised C-strain vaccine

The aim of this study was to investigate the uptake of new spherical and cuboid baits by wild boar and domestic pigs and to evaluate the stability of lyophilised C-strain vaccine stored at different environmental temperatures. New baits were designed to improve the consumption of the vaccine against classical swine fever by young wild boar. Our uptake studies showed that neither wild boar nor domestic pigs at the age of 2 months picked up the baits at all. Although the animals began to pick up the baits incompletely at the age of 3 months, a complete uptake of both the new baits and the older ones was only observed from the age of 4 (domestic pigs) and 4.5 (wild boar) months on. Nevertheless, the larger spherical baits with a diameter of 3 cm were taken up more effectively than the recent vaccine baits. As expected, lyophilised vaccine showed a higher stability than liquid vaccine, especially at temperatures ≥24°C. Independently of the stabiliser (GS4 or TSM) used, there are no differences between the virus titres detected within a storage period of 7 days. As the lyophilised C-strain vaccine was more stable at higher temperatures than the liquid vaccine formulation, we recommend to use lyophilised vaccine for oral immunisation of wild boar in the future, as oral vaccination is also carried out in the summertime.     

The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat

Classical swine fever virus (CSFV) outer surface E2 glycoprotein represents an important target to induce protective immunization during infection but the influence of N-glycosylation pattern in antigenicity is yet unclear. In the present work, the N-glycosylation of the E2-CSFV extracellular domain expressed in goat milk was determined. Enzymatic N-glycans releasing, 2-aminobenzamide (2AB) labeling, weak anion-exchange and normal-phase HPLC combined with exoglycosidase digestions and mass spectrometry of 2AB-labeled and unlabeled N-glycans showed a heterogenic population of oligomannoside, hybrid and complex-type structures. The detection of two Man₈GlcNAc₂ isomers indicates an alternative active pathway in addition to the classical endoplasmic reticulum processing. N-acetyl or N-glycolyl monosialylated species predominate over neutral complex-type N-glycans. Asn207 site-specific micro-heterogeneity of the E2 most relevant antigenic and virulence site was determined by HPLC-mass spectrometry of glycopeptides. The differences in N-glycosylation with respect to the native E2 may not disturb the main antigenic domains when expressed in goat milk.     

Oral vaccination against classical swine fever with a chimeric <Emphasis Type="Italic">Pestivirus</Emphasis>: comparative investigations of liquid and lyophilized virus

The goal of this study was to evaluate the efficacy of the chimeric marker vaccine candidate CP7_E2alf in different formulations for oral immunization against classical swine fever (CSF). In the first experiment, three wild boars were vaccinated orally with the liquid chimeric virus CP7_E2alf, whereas in the second experiment, four wild boars and four domestic pigs were immunized with the lyophilized chimera administered in gelatine capsules and new baits. The chimera was safe for wild boars and domestic pigs. All animals vaccinated orally with the liquid chimera were seropositive 21 days after vaccination, and neither viraemia nor virus shedding were observed after challenge with a highly virulent CSF virus. At necropsy, viral genome of the challenge virus was detected in some organs of all surviving wild boars. Lyophilized chimera administered orally did not protect the animals. The reasons for the inefficacy of the lyophilized vaccine virus are discussed. Irrespective of the negative result with lyophilized virus, the study and previous experiences (Reimann et al., Virology, 307:213–227, 2004) suggest that the chimera CP7_E2alf is a potential CSF marker vaccine candidate.